Singular Genomics Systems, a developer of next-gen sequencing tech, files for a $100 million IPO May 7, 2021
Denali Therapeutics Presents Positive Results from Phase 1 and Phase 1b Studies of Its LRRK2 Inhibitor, BIIB122/DNL151, Supporting Late-Stage Development Plans in Parkinson’s Disease May 6, 2021
Caribou Biosciences Announces Appointment of Industry Leader Andrew Guggenhime to its Board of Directors May 5, 2021
Checkmate Pharmaceuticals Announces Initiation of Patient Dosing in Potential Registration Trial of Vidutolimod (CMP-001) in Patients with Anti-PD-1 Refractory Advanced Melanoma May 4, 2021
Centivo launches new health plan for self-funded employers in Iowa utilizing Incirca Health Network, powered by MercyOne May 4, 2021
Denali Therapeutics Presents Positive Results from Phase 1 and Phase 1b Studies of Its LRRK2 Inhibitor, BIIB122/DNL151, Supporting Late-Stage Development Plans in Parkinson’s Disease May 1, 2021